Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of H3B-6527 in advanced hepatocellular carcinoma; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cancer
• Hepatic Carcinoma
• Hepatocellular Carcinoma
• Liver Cancer
• Liver Neoplasms

Drugs mentioned

• H3B-6527 (H3B-6527)

Snippet

Sponsor: H3 Biomedicine Inc. | Conditions: Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2023-11-13